Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Isomerase Therapeutics

Isomerase Therapeutics
2012 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Corporate LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical drugs. The company offers drug discovery and development services and focuses on optimized microbial natural products.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Suite 9
  • Science Village, Chesterford Research Park
  • Cambridge CB10 1XL
  • England, United Kingdom

+44 01223 000000

Isomerase Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Isomerase Therapeutics‘s full profile, request access.

Request full access to PitchBook

Isomerase Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Isomerase Therapeutics‘s full profile, request access.

Request full access to PitchBook

Isomerase Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Matthew Gregory Ph.D Chief Executive Officer
Steven Moss Ph.D Chief Technology Officer
Steven Martin Ph.D Chief Business Officer
Sarah Higginbotham Ph.D Project Manager